On May 16, 2023, the U.S. Food and Drug Administration (FDA) approved spinal cord stimulation (SCS) devices from the pharmaceutical company Abbott to treat chronic back pain in people who have not had ...

Christopher Maher holds a research fellowship funded by the National Health and Medical Research Council. Caitlin Jones does not work for, consult, own shares in or receive funding from any company or ...

Spinal cord stimulators are electrical devices that are surgically implanted in the body to treat long-term pain. They have a battery pack and leads that deliver electrical impulses directly to the ...

Ian Harris receives funding from research organisations unrelated to spinal cord stimulators. He was interviewed for the Four Corners episode referred to. Adrian C Traeger receives research funding ...

Spinal cord stimulation, a medical technology suggested to treat people with chronic back pain, does not provide long-term relief and may cause harm, according to a Cochrane Review released today.

Abbott is putting the old adage that “good things come in threes” to the test, with its fourth FDA approval in less than a year for its spinal cord stimulation (SCS) systems. The latest regulatory nod ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

With epidural electrical stimulation (EES) of the cervical spine, researchers successfully improved arm and hand mobility in two stroke patients who otherwise had no treatment available for their ...

Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Independent studies suggested that spinal cord stimulation ...